Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05368012 · ClinicalTrials.gov registry record · Phase 4
MIDCAB (Mid-Calf Block) for Foot Surgery
A Phase 4 study of Ankle Surgery and Foot Surgery, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05368012 is a Phase 4 study of Ankle Surgery and Foot Surgery that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05368012, a Phase 4 study of Ankle Surgery and Foot Surgery, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
MIDCAB is defined as a group of ultrasound guided distal nerve blocks at the level of the individual branches. It is similar to an Ultrasound Guided (USG) Ankle block but the probe is placed higher on the calf covering all and any surgery of the foot and ankle, providing prolonged analgesia since we are blocking the individual nerves and preserving the proximal motor function. This study is determining the potential therapeutic effect of MIDCAB during the hospital stay and recovery period in patients undergoing foot/ankle surgeries that require spinal anesthetic and peripheral nerve blocks. A total of 20 patients at HSS will participate to see if MIDCAB is not only effective at providing analgesia (pain relief) but to see if it allows allows patients to maintain motor function (movement) of the foot and ankle unlike the current popliteal block which is done above the knee and prevents patients from moving their foot. During the course of the study we will also be looking at patients numeric pain scores with movement and at rest along with post-operative nausea and vomiting, the presence of numbness and it patients can move their foot. Along with all of these, the study will also look at the amount of opioid pain medications taken by patients along with medication-related side effects. As a result, the study will be used to determine if MIDCAB provides analgesia for patients undergoing foot/ankle surgery while allowing them to maintain movement of the foot. This pilot study will also be used to gather preliminary data that will allow us to perform a power analysis for a subsequent randomized clinical control trial that would compare the MIDCAB block to the popliteal block.
Conditions Studied
Interventions
- DRUG MIDCAB
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2022-11-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05368012
The ClinicalTrials.gov registry entry for NCT05368012 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ankle Surgery appearing as the primary indexed condition, and to 1 intervention - of which MIDCAB is the first listed.
NCT05368012 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05368012 about?
NCT05368012 is a clinical study titled "MIDCAB (Mid-Calf Block) for Foot Surgery". MIDCAB is defined as a group of ultrasound guided distal nerve blocks at the level of the individual branches. It is similar to an Ultrasound Guided (USG) Ankle block but the probe is placed higher on the calf covering all and any surgery of the foot and ankle, providing prolonged analgesia since we...
What is the current status of trial NCT05368012?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2022-07-21. Estimated completion is 2022-11-29.
What conditions does trial NCT05368012 study?
This clinical trial studies the following conditions: Ankle Surgery, Foot Surgery.
What interventions are being tested in trial NCT05368012?
The interventions under investigation include: MIDCAB (DRUG).
Who is sponsoring clinical trial NCT05368012?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05368012 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.